Decision based on recommendation from DSMC following study data reviewSacituzumab govitecan has the potential to be the first FDA-approved antibody-drug […]
EMERYVILLE, Calif., April 06, 2020 (GLOBE NEWSWIRE) — Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next […]
OTTAWA, April 06, 2020 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived […]
MORRIS PLAINS, N.J., April 06, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]